 |
|
|
| |
Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results
|
| |
| |
Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
Kavita Radhakrishnan1, Adrian M. Di Bisceglie2, K. Rajender Reddy3, Joseph K. Lim4, Josh Levitsky5, Alexander Kuo6, Mohamed A. Hassan7, Jama M. Darling8,
Jordan J. Feld9, Lucy Akushevich8, Monika Vainorius8, David R. Nelson10, Michael W. Fried8, Robert S. Brown11, Norah Terrault1
1. University of California, San Francisco 2. Saint Louis University School of Medicine 3. University of Pennsylvania. 4. Yale University School of Medicine 5. Northwestern University, 6. Virginia Mason Medical Center 7. University of Minnesota 8. University of North Carolina Chapel Hill, 9. Toronto Western Hospital Liver Center. 10. University of Florida, Gainesville,11. Weill Cornell Medical School
|
| |
|
|
|
|
|
